215 related articles for article (PubMed ID: 2409985)
1. The association between Mi-2 antibodies and dermatomyositis.
Targoff IN; Reichlin M
Arthritis Rheum; 1985 Jul; 28(7):796-803. PubMed ID: 2409985
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody profiles in the sera of European patients with myositis.
Brouwer R; Hengstman GJ; Vree Egberts W; Ehrfeld H; Bozic B; Ghirardello A; Grøndal G; Hietarinta M; Isenberg D; Kalden JR; Lundberg I; Moutsopoulos H; Roux-Lombard P; Vencovsky J; Wikman A; Seelig HP; van Engelen BG; van Venrooij WJ
Ann Rheum Dis; 2001 Feb; 60(2):116-23. PubMed ID: 11156543
[TBL] [Abstract][Full Text] [Related]
3. Anti-Jo-1 antibodies in polymyositis or dermatomyositis: evaluation by ELISA using recombinant fusion protein Jo-1 as antigen.
Nishikai M; Ohya K; Kosaka M; Akiya K; Tojo T
Br J Rheumatol; 1998 Apr; 37(4):357-61. PubMed ID: 9619882
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system.
Nishikai M; Reichlin M
Arthritis Rheum; 1980 Aug; 23(8):881-8. PubMed ID: 7406938
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
Muro Y; Ishikawa A; Sugiura K; Akiyama M
Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
[TBL] [Abstract][Full Text] [Related]
6. Humoral immunity in polymyositis/dermatomyositis.
Targoff IN
J Invest Dermatol; 1993 Jan; 100(1):116S-123S. PubMed ID: 8423380
[TBL] [Abstract][Full Text] [Related]
7. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
8. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
[TBL] [Abstract][Full Text] [Related]
9. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis.
Yoshida S; Akizuki M; Mimori T; Yamagata H; Inada S; Homma M
Arthritis Rheum; 1983 May; 26(5):604-11. PubMed ID: 6405755
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis.
Fujimoto M; Murakami A; Kurei S; Okiyama N; Kawakami A; Mishima M; Sato S; Seishima M; Suda T; Mimori T; Takehara K; Kuwana M
J Dermatol Sci; 2016 Dec; 84(3):272-281. PubMed ID: 27693019
[TBL] [Abstract][Full Text] [Related]
11. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
[TBL] [Abstract][Full Text] [Related]
12. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
[TBL] [Abstract][Full Text] [Related]
13. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to Mi-1 in SLE: relationship to other precipitins and reaction with bovine immunoglobulin.
Targoff IN; Raghu G; Reichlin M
Clin Exp Immunol; 1983 Jul; 53(1):76-82. PubMed ID: 6409478
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
[TBL] [Abstract][Full Text] [Related]
16. Novel autoantibodies against muscle-cell membrane proteins in patients with myositis.
Stuhlmüller B; Jerez R; Hausdorf G; Barthel HR; Meurer M; Genth E; Kalden JR; Burmester GR
Arthritis Rheum; 1996 Nov; 39(11):1860-8. PubMed ID: 8912508
[TBL] [Abstract][Full Text] [Related]
17. Antibody to threonyl-transfer RNA synthetase in myositis sera.
Targoff IN; Arnett FC; Reichlin M
Arthritis Rheum; 1988 Apr; 31(4):515-24. PubMed ID: 3128989
[TBL] [Abstract][Full Text] [Related]
18. Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase.
Walker EJ; Tymms KE; Webb J; Jeffrey PD
J Immunol Methods; 1987 Feb; 96(2):149-56. PubMed ID: 3100649
[TBL] [Abstract][Full Text] [Related]
19. Immunoserological aspects of idiopathic inflammatory muscle disease.
Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T
Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964
[TBL] [Abstract][Full Text] [Related]
20. Immune manifestations of inflammatory muscle disease.
Targoff IN
Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
